Research Papers

25 of 325 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Hepatitis C Attributable Healthcare Costs and Mortality among Immigrants: A Population-Based Matched Cohort Study.
Erman A; Sahakyan Y; Everett K; Greenaway C; Janjua N; Kwong JC; Wong WWL; Lu H; Sander B.
Can J Gastroenterol Hepatol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Prevalence of Esophageal Eosinophilia, Eosinophilic Esophagitis, and Lymphocytic Gastritis in Children with Celiac Dise…
Alaifan MA; Khayat A; Bokhary RY; Ibrahim A; Bin-Taleb Y; Alhussaini BH; Saadah OI.
Can J Gastroenterol Hepatol (Unknown)
Published: 2024
2/6 Transparent
<i>miR-325-3p</i> Reduces Proliferation and Promotes Apoptosis of Gastric Cancer Cells by Inhibiting Human Antigen R.
Huang Z; Luo Y; Chen C; Zhou C; Su Z; Cai C; Li X; Wu W.
Can J Gastroenterol Hepatol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Gambogic Acid Inhibits Gastric Cancer Cell Proliferation through Necroptosis.
Wang S; Wang Y; Zhu H; Chen M; Zhang L.
Can J Gastroenterol Hepatol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Platelet-to-Monocyte Ratio as a Novel Promising Agent for the Prognosis of Hepatitis B Virus-Associated Decompensated C…
Zhou J; Li X; Wang M; Gu C; Liu J.
Can J Gastroenterol Hepatol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Plasma S100A8 and S100A9 Are Strong Prognostic Factors for Hepatitis B Virus-Related Acute-on-Chronic Liver Failure.
Zhang Y; Zhang X; Han J; Guo Y; He J; Yang F; Mao R; Huang Y; Zhang J.
Can J Gastroenterol Hepatol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Diabetes and Metabolic Disorders: Their Impact on Cardiovascular Events in Liver Transplant Patients.
Di Cola S; Cusi G; Lapenna L; Gazda J; Fonte S; Mattana M; Mennini G; Pasqualetti P; Merli M.
Can J Gastroenterol Hepatol (Unknown)
Published: 2023
2/6 Transparent
SPI1 Mediates N-Myristoyltransferase 1 to Advance Gastric Cancer Progression via PI3K/AKT/mTOR Pathway.
Qiu P; Li X; Gong M; Wen P; Wen J; Xu L; Wang G.
Can J Gastroenterol Hepatol (Unknown)
Published: 2023
2/6 Transparent
Higher Neutrophil-to-Lymphocyte Ratio (NLR) Is a Preoperative Inflammation Biomarker of Poor Prognosis in HIV-Infected …
Deng L; Si Y; Wu Q; Cao Y; Lian S; Li L.
Can J Gastroenterol Hepatol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Disparate Intent-to-Treat Outcomes for Pediatric Liver Transplantation Based on Indication.
Lang A; Goff C; Montgomery A; Lynn J; Kamepalli S; Goss J; Rana A.
Can J Gastroenterol Hepatol (Unknown)
Published: 2023
2/6 Transparent
Surgical Management of Recurrence of Primary Intrahepatic Bile Duct Stones.
Xia H; Zhang H; Xin X; Liang B; Yang T; Liu Y; Wang J; Meng X.
Can J Gastroenterol Hepatol (Unknown)
Published: 2023
2/6 Transparent
Construction and Analysis of Hepatocellular Carcinoma Prognostic Model Based on Random Forest.
Wang Y; Ma L; Xue P; Qin B; Wang T; Li B; Wu L; Zhao L; Liu X.
Can J Gastroenterol Hepatol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Diagnostic Delay in Coeliac Disease: A Survey among Danish Patients.
Kårhus LL; Hansen S; Rumessen JJ; Linneberg A.
Can J Gastroenterol Hepatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
A Comprehensive Hepatitis B Surface Antigen-Positive Patient-Centered Screening and Linkage to Care Strategies Targetin…
Cai D; Zhang D; Hu P; Ren H.
Can J Gastroenterol Hepatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Overexpression of microRNA-211 in Functional Dyspepsia via Downregulation of the Glial Cell Line-Derived Neurotrophic F…
Wang J; Gu S; Qin B.
Can J Gastroenterol Hepatol (Unknown)
Published: 2022
3/6 Transparent
Data
Reduction of Hepatitis B Surface Antigen May Be More Significant in PEGylated Interferon-Alpha Therapy Combined with Nu…
Xie Y; Zhu H; Guo Y; Ma Z; Qi X; Yang F; Mao R; Zhang J.
Can J Gastroenterol Hepatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Comprehensive Analysis of N6-Methyladenosine (m<sup>6</sup>A) RNA Methylation Regulators and Tumour Microenvironment Ce…
Liu D; Yuan M; Wang Z; Sun L; Fang Y; Ma X; Zhang L; Xing Y; Zhu J; Liu Y; Zhu W; Bao S; Jia Y; Wang Y.
Can J Gastroenterol Hepatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Risk of Severe Illness and Risk Factors of Outcomes of COVID-19 in Hospitalized Patients with Chronic Liver Disease in …
Krishnan A; Prichett L; Liu Y; Ting PS; Alqahtani SA; Kim AK; Ma M; Hamilton JP; Woreta TA; Chen PH.
Can J Gastroenterol Hepatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Finding Cases of Hepatitis C for Treatment Using Automated Screening in the Emergency Department is Effective, but What…
Prince DS; Girolamo JD; Pipicella JL; Bagatella M; Kayes T; Alvaro F; Maley M; Foo H; Middleton PM; Levy MT.
Can J Gastroenterol Hepatol (Unknown)
Published: 2022
2/6 Transparent
Depletion and Reversal of Hepatocellular Carcinoma Inducing CTL through ER Stress-Dependent PERK-CHOP Signaling Pathway.
Guo M; Wang W; Bai W; Bai Z; Chen W; Su Y; Wu J.
Can J Gastroenterol Hepatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Diagnostic Challenges of <i>Helicobacter pylori</i> Infection in Ethiopia: A Community-Based Cross-Sectional Study.
Gudina EK; Amare H; Ali S; Berhane Arefayine M; Tewolde D; Tesfaye Eshete M; Jebena MG; Wieser A; Froeschl G; Tesfaye M; Desalegn H; Gashaw M.
Can J Gastroenterol Hepatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Pathological Characteristics, Prognostic Determinants and the Outcome of Patients Diagnosed with Colorectal Adenocarcin…
Uwamariya D; Ruhangaza D; Rugwizangoga B.
Can J Gastroenterol Hepatol (Unknown)
Published: 2022
2/6 Transparent
Neutrophil to Lymphocyte Ratio and Spontaneous Bacterial Peritonitis among Cirrhotic Patients: A Systematic Review and …
Seyedi SA; Nabipoorashrafi SA; Hernandez J; Nguyen A; Lucke-Wold B; Nourigheimasi S; Khanzadeh S.
Can J Gastroenterol Hepatol (Unknown)
Published: 2022
2/6 Transparent
The Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy Based on FOLFIRI for Advanced Intrahepatic Cholangioc…
Huang P; Huang X; Zhou Y; Yang G; Sun Q; Shi G; Chen Y.
Can J Gastroenterol Hepatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Autoimmune Hepatitis with Acute Presentation: Clinical, Biochemical, and Histological Features of 126 Patients.
Urzúa Á; Pizarro C; Gajardo A; Poniachik R; Pavez C; Cattaneo M; Brahm J; Carreño L; Poniachik J.
Can J Gastroenterol Hepatol (Unknown)
Published: 2022
2/6 Transparent